In this study, we systematically investigated the effects of different thresholding algorithms on the quantification of whole-body molecular tumor volume in [68Ga]Ga-PSMA-11-PET of patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy. This evidence concerns the gene FOLH1 and prostate carcinoma.